Nakayama M, Saito H, Murakami K, Oshima H, Oshima M
Cancer Res Commun. 2024; 5(1):13-23.
PMID: 39641656
PMC: 11695814.
DOI: 10.1158/2767-9764.CRC-24-0471.
Anbazhagan M, Sharma G, Murthy S, Maddipatla S, Kolachala V, Dodd A
Cell Commun Signal. 2024; 22(1):493.
PMID: 39396982
PMC: 11472582.
DOI: 10.1186/s12964-024-01879-1.
Wismayer R, Matthews R, Whalley C, Kiwanuka J, Kakembo F, Thorn S
BMC Cancer. 2024; 24(1):1212.
PMID: 39350061
PMC: 11440721.
DOI: 10.1186/s12885-024-12967-3.
Dwyer M, Aumiller J, Wedegaertner P
Mol Pharmacol. 2024; 106(5):198-215.
PMID: 39187387
PMC: 11493338.
DOI: 10.1124/molpharm.124.000743.
Nag J, Appasamy P, Malka H, Sedley S, Bar-Shavit R
Int J Mol Sci. 2024; 25(15).
PMID: 39125653
PMC: 11311281.
DOI: 10.3390/ijms25158083.
Arachidonic acid metabolism as a novel pathogenic factor in gastrointestinal cancers.
Lu W, Aihaiti A, Abudukeranmu P, Liu Y, Gao H
Mol Cell Biochem. 2024; 480(2):1225-1239.
PMID: 38963615
DOI: 10.1007/s11010-024-05057-2.
Emerging modes of regulation of neuromodulatory G protein-coupled receptors.
Gonzalez-Hernandez A, Munguba H, Levitz J
Trends Neurosci. 2024; 47(8):635-650.
PMID: 38862331
PMC: 11324403.
DOI: 10.1016/j.tins.2024.05.008.
Lung Cancers: Parenchymal Biochemistry and Mechanics.
Lecarpentier Y, Tremblay B, Locher C, Schussler O, Vallee A, Locher C
Cells. 2024; 13(5.
PMID: 38474391
PMC: 10931145.
DOI: 10.3390/cells13050427.
WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses.
Mortezaee K
Clin Exp Med. 2024; 24(1):15.
PMID: 38280119
PMC: 10822012.
DOI: 10.1007/s10238-023-01274-z.
Design, Synthesis, and Evaluation of New Imidazo[1,2-]pyridine Derivatives as Cyclooxygenase-2 Inhibitors.
Ahmadi N, Khoramjouy M, Azami Movahed M, Amidi S, Faizi M, Zarghi A
Anticancer Agents Med Chem. 2024; 24(7):504-513.
PMID: 38275051
DOI: 10.2174/0118715206269563231220104846.
Lipids as mediators of cancer progression and metastasis.
Vogel F, Chaves-Filho A, Schulze A
Nat Cancer. 2024; 5(1):16-29.
PMID: 38273023
DOI: 10.1038/s43018-023-00702-z.
Single-Component Dual-Functional Autoboost Strategy by Dual Photodynamic and Cyclooxygenase-2 Inhibition for Lung Cancer and Spinal Metastasis.
Wang B, Lu Z, Song M, He X, Hu Z, Liang H
Adv Sci (Weinh). 2024; 11(12):e2303981.
PMID: 38224203
PMC: 10966547.
DOI: 10.1002/advs.202303981.
Prostaglandin E2 Exposure Disrupts E-Cadherin/Caveolin-1-Mediated Tumor Suppression to Favor Caveolin-1-Enhanced Migration, Invasion, and Metastasis in Melanoma Models.
Lobos-Gonzalez L, Orostica L, Diaz-Valdivia N, Rojas-Celis V, Campos A, Duran-Jara E
Int J Mol Sci. 2023; 24(23).
PMID: 38069269
PMC: 10707163.
DOI: 10.3390/ijms242316947.
Exploring extracellular matrix and prostaglandin pathway alterations across varying resection margin distances of right-sided colonic adenocarcinoma.
Suwatthanarak T, Tanjak P, Suwatthanarak T, Acharayothin O, Thanormjit K, Chaiboonchoe A
BMC Cancer. 2023; 23(1):1202.
PMID: 38062443
PMC: 10702019.
DOI: 10.1186/s12885-023-11595-7.
Autocrine regulation of tumor cell repopulation by Hsp70-HMGB1 alarmin complex.
Sverchinsky D, Alhasan B, Mikeladze M, Lazarev V, Kuznetcova L, Morshneva A
J Exp Clin Cancer Res. 2023; 42(1):279.
PMID: 37880798
PMC: 10598926.
DOI: 10.1186/s13046-023-02857-0.
EP2 inhibition restores myeloid metabolism and reverses cognitive decline.
Lushington R, Camilli S, Pascual F, Lockey R, Kolliputi N
J Allergy Clin Immunol Glob. 2023; 2(2):100082.
PMID: 37780795
PMC: 10509962.
DOI: 10.1016/j.jacig.2023.100082.
Perish in the Attempt: Regulated Cell Death in Regenerative and Nonregenerative Tissue.
Li S, Tao G
Antioxid Redox Signal. 2023; 39(16-18):1053-1069.
PMID: 37218435
PMC: 10715443.
DOI: 10.1089/ars.2022.0166.
Cell-free circulating tumor RNAs in plasma as the potential prognostic biomarkers in colorectal cancer.
Jin N, Kan C, Pei X, Cheung W, Ng S, Wong H
Front Oncol. 2023; 13:1134445.
PMID: 37091184
PMC: 10115432.
DOI: 10.3389/fonc.2023.1134445.
Electrophilic reactive aldehydes as a therapeutic target in colorectal cancer prevention and treatment.
Gobert A, Asim M, Smith T, Williams K, Barry D, Allaman M
Oncogene. 2023; 42(20):1685-1691.
PMID: 37037901
PMC: 10182918.
DOI: 10.1038/s41388-023-02691-w.
The discovery of cyclic γ-AApeptides as the promising ligands targeting EP2.
Gu M, Yu Y, Xue M, Jiang J, Cai J
Bioorg Med Chem Lett. 2023; 87:129255.
PMID: 36965536
PMC: 10141659.
DOI: 10.1016/j.bmcl.2023.129255.